Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Floriano Paes Silva Junior"'
Autor:
Luiz Carlos Saramago, Marcos V. Santana, Bárbara Figueira Gomes, Rafael Ferreira Dantas, Mario R. Senger, Pedro Henrique Oliveira Borges, Vivian Neuza dos Santos Ferreira, Alice dos Santos Rosa, Amanda Resende Tucci, Milene Dias Miranda, Petra Lukacik, Claire Strain-Damerell, C. David Owen, Martin Austin Walsh, Sabrina Baptista Ferreira, Floriano Paes Silva-Junior
Publikováno v:
Journal of Chemical Information and Modeling. 63:2866-2880
Autor:
Lucas Villas Bôas Hoelz, Anna C. Cunha, Frederico Silva Castelo Branco, Mônica M. Bastos, Henayle Fernandes Canzian, Nubia Boechat, Andressa Paula de Oliveira, Jackson A. L. C. Resende, Luiz Claudio Ferreira Pimentel, Vinícius R. Campos, Rafael Ferreira Dantas, Floriano Paes Silva Junior
Publikováno v:
Beilstein Journal of Organic Chemistry
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2260-2269 (2021)
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2260-2269 (2021)
The enzyme tyrosine kinase BCR-Abl-1 is the main molecular target in the treatment of chronic myeloid leukemia and can be competitively inhibited by tyrosine kinase inhibitors such as imatinib. New potential competitive inhibitors were synthesized us
Autor:
Lucas Villas Bôas Hoelz, Nubia Boechat, Larissa C. Gomes, Flavia da Cunha Vasconcelos, Liviane D. de Azevedo, Mônica M. Bastos, Andressa Paula de Oliveira, Ana C. M. de Almeida, Rafael Ferreira Dantas, Floriano Paes Silva Junior, Raquel Ciuvalschi Maia
Publikováno v:
Medicinal Chemistry Research. 26:2929-2941
Imatinib was the first representative of the class of Breakpoint cluster region-Abelson murine leukemia viral oncogene homolog (BCR-ABL) tyrosine kinase inhibitors used for the treatment of chronic myeloid leukemia. Second-generation and third-genera
Autor:
Paulo André Teixeira de Moraes Gomes, Marcos Veríssimo de Oliveira Cardoso, Gevanio Bezerra de Oliveira Filho, Floriano Paes Silva Junior, Regina Celia Bressan Queiroz de Figueiredo, José Wanderlan Pontes Espíndola, Lívia Bandeira Costa, Thays Gabrielle de Jesus Silva, Ana Cristina Lima Leite, Julio Martin, Pedro Henrique Monteiro Torres
Publikováno v:
Bioorganic & Medicinal Chemistry. 24:1608-1618
Chagas disease is a tropical disease caused by the parasite Trypanosoma cruzi, which is endemic in Central and South America. Few treatments are available with effectiveness limited to the early (acute) stage of disease, significant toxicity and wide
Publikováno v:
Revista Virtual de Química. 11:1657-1658
This book presents the theoretical foundations of Systems Biology, as well as its application in studies on human hosts, pathogens and associated diseases. This book presents several chapters written by renowned experts in the field. Some topics dis
Publikováno v:
Toxicon : official journal of the International Society on Toxinology. 146
Phospholipases A2 (PLA2s) comprise a superfamily of glycerophospholipids hydrolyzing enzymes present in many organisms in nature, whose catalytic activity was majorly unveiled by analysis of snake venoms. The latter have pharmaceutical and biotechnol
Autor:
Álvaro Paiva Braga de Sousa, Bogar Omar Araujo Montoya, Nathália da Costa e Silva, Floriano Paes Silva Junior
Publikováno v:
Anais do III Simpósio Internacional de Imunobiológicos.
Autor:
Luiz Claudio Ferreira Pimentel, Lucas Villas Boas Hoelz, Henayle Fernandes Canzian, Frederico Silva Castelo Branco, Andressa Paula de Oliveira, Vinicius Rangel Campos, Floriano Paes Silva Júnior, Rafael Ferreira Dantas, Jackson Antônio Lamounier Camargos Resende, Anna Claudia Cunha, Nubia Boechat, Mônica Macedo Bastos
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2260-2269 (2021)
The enzyme tyrosine kinase BCR-Abl-1 is the main molecular target in the treatment of chronic myeloid leukemia and can be competitively inhibited by tyrosine kinase inhibitors such as imatinib. New potential competitive inhibitors were synthesized us
Externí odkaz:
https://doaj.org/article/52c4d12e69cd40e2bc4c1ffb5eeb6e3c
Autor:
Aline R. Silveira, Fernanda Carvalho de Queiroz Mello, Raquel Lima de Figueiredo Teixeira, Pedro Hernan Cabello, Adalberto R. Santos, Afrânio Lineu Kritski, Philip Noel Suffys, Antonio Basílio de Miranda, Marcelo Fouad Rabahi, Floriano Paes Silva Junior, Leila Mendonça-Lima
Publikováno v:
Mutation research. 683(1-2)
N-Acetyltransferase 2 (NAT2) metabolizes a variety of xenobiotics that includes many drugs, chemicals and carcinogens. This enzyme is genetically variable in human populations and polymorphisms in the NAT2 gene have been associated with drug toxicity